Procter & Gamble Hygiene and Health Care Limited — Important, 11-02-2025: Financial Result Updates

Procter & Gamble Hygiene and Health Care Limited has announced a board meeting to discuss the financial results for the quarter ended December 31, 2024.

Consolidated revenue from operations for the quarter stood at ₹1,24,763 lakh (1,247.63 cr), reflecting a 9.8% increase from ₹1,13,516 lakh (1,135.16 cr) in the previous quarter. This growth is attributed to solid demand across product lines and effective market expansion strategies.

Net profit for the quarter is reported at ₹26,859 lakh (268.59 cr), up 26.8% from ₹21,190 lakh (211.90 cr) year-over-year. The Earnings Per Share (EPS) came in at ₹82.74 compared to ₹65.28 last year, indicating improved operational efficiency and profitability driven by cost management initiatives.

Total expenses for the quarter were ₹89,321 lakh (893.21 cr), a 4.4% hike sequentially. Key cost drivers included an increase in employee benefits and advertising expenses.

The balance sheet remains robust, with total assets of ₹2,09,695 lakh (2,096.95 cr) and a current ratio indicating healthy liquidity. Cash and cash equivalents increased to ₹77,443 lakh (774.43 cr), suggesting strong operational cash flow.

Overall, the company's strategic focus on health and hygiene products and effective cost management positions it well for future growth. Given these positive indicators, the suggested stance is to buy, considering the potential for further gains in upcoming quarters.